Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors

Details for Australian Patent Application No. 2007309468 (hide)

Owner Signal Pharmaceuticals, LLC.

Inventors Parnes, Jason Simon; Lee, Branden G.; Mederos, Maria Mercedes Delgado; Albers, Ronald J.; Sapienza, John Joseph; Mortensen, Deborah Sue; Huang, Dehua; Schwarz, Kimberly Lyn; Papa, Patrick William; Riggs, Jennifer R.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007309468

PCT Pub. Number WO2008/051494

Priority 60/853,135 19.10.06 US

Filing date 18 October 2007

Wipo publication date 2 May 2008

Acceptance publication date 17 May 2012

International Classifications

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/522 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 475/00 (2006.01) Heterocyclic compounds containing pteridine ring systems

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051494 Priority application(s): WO2008/051494

17 May 2012 Application Accepted

  Published as AU-B-2007309468

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309470-Use of IL-1 antagonists to treat gout and pseudogout

2007309467-Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors